Eqis Capital Management, Inc. Abbott Laboratories Transaction History
Eqis Capital Management, Inc.
- $1.15 Billion
- Q4 2024
A detailed history of Eqis Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 8,803 shares of ABT stock, worth $1.16 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
8,803
Previous 8,396
4.85%
Holding current value
$1.16 Million
Previous $957,000
3.97%
% of portfolio
0.09%
Previous 0.08%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,303Shares Held
1.34BCall Options Held
9.84MPut Options Held
8.59M-
Vanguard Group Inc Valley Forge, PA169MShares$22.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$10.1 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.96 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.13 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $231B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...